businesspress24.com - Neptune to Hold Conference Call to Discuss Second Quarter Results for the Interim Period Ended Septe
 

Neptune to Hold Conference Call to Discuss Second Quarter Results for the Interim Period Ended September 30, 2017

ID: 1525666

(firmenpresse) - LAVAL, QUEBEC -- (Marketwired) -- 10/24/17 -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT)(TSX: NEPT), announces that it will be holding a conference call on November 14, 2017 at 5:00 PM (EST) to discuss its second quarter results for the interim period ended September 30, 2017.

The second quarter results press release will be issued on the same day at 4:00 PM (EST).

Conference Call Details:

A replay of the call will be available for replay two hours after the call''s completion, until December 14, 2017. The telephone numbers to access the replay of the call are 1 (416) 621-4642 or 1 (800) 585-8367 (toll-free), Conference ID 90228278. The archive of the webcast, along with its accompanying presentation, will also be made available immediately in the Investors section of Neptune''s website under Investor Events and Presentations.

About Neptune Technologies & Bioressources Inc.

Neptune is a wellness products company, with more than 50 years of combined experience in the industry. The Company develops turnkey solutions available in various unique delivery forms, offers specialty ingredients such as MaxSimil®, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and a variety of other marine and seed oils. Neptune also sells premium krill oil directly to consumers through web sales at . Leveraging our scientific, technological and innovative expertise Neptune is working to develop unique extractions in high potential growth segments such as in the medical cannabis field.

Neptune is also pursuing opportunities in the prescription drug markets, through its 34% owned subsidiary Acasti Pharma Inc. ("Acasti"). Acasti focuses on the research, development and commercialization of omega-3 phospholipid therapies for the treatment of severe hypertriglyceridemia.

The Company''s head office is located in Laval, Quebec.





Contacts:
Neptune Wellness Solutions
Mario Paradis
VP & CFO, Neptune

1.450.687.2262 x236

Investor Relations Contact (Canada)
Pierre Boucher
MaisonBrison
1.514.731.0000


Investor Relations Contact (U.S.)
Ed McGregor/Jody Burfening
LHA
1.212.838.3777

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Verato and Audience Acuity Announce Partnership for Enhanced Patient Matching
Brain Armor Foundation to Fund Head Trauma Research Study on Elite Canadian Rugby Athletes
Bereitgestellt von Benutzer: Marketwired
Datum: 24.10.2017 - 09:00 Uhr
Sprache: Deutsch
News-ID 1525666
Anzahl Zeichen: 3706

contact information:
Contact person:
Town:

LAVAL, QUEBEC


Phone:

Kategorie:

Alternative


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 454 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Neptune to Hold Conference Call to Discuss Second Quarter Results for the Interim Period Ended September 30, 2017
"
steht unter der journalistisch-redaktionellen Verantwortung von

Neptune Technologies & Bioressources Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Neptune Technologies & Bioressources Inc.



 

Who is online

All members: 10 561
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 72


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.